Press Announcements > FDA alerts healthcare providers, women about risks associated with improper use of rupture of membranes tests

Press Announcements > FDA alerts healthcare providers, women about risks associated with improper use of rupture of membranes tests





FDA alerts healthcare providers, women about risks associated with improper use of rupture of membranes tests

The U.S. Food and Drug Administration today alerted women and their doctors about serious adverse events related to the improper use of tests intended as an aid in detecting if a pregnant woman’s water has broken (also known as a rupture of the membranes containing amniotic fluid). A rupture of the membranes (ROM) can pose immediate and severe risks to the patient and developing fetus without proper patient management and timely intervention. Continue reading...